Docket HopperPart I · Bills · 119th H.R. 586
H.R. 586 · 119th CongressArmed Forces and National Security

Vietnam Veterans Liver Fluke Cancer Study Act passed the House 76 days after introduction and awaits a vote in the Senate

Sponsored by LaLota, Nick R-NY · 8 cosponsors: 5 Democrats, 3 Republicans
IntroducedJan 21, 2025
Reported—
Passed one chamberApr 7, 2025
Passed both—
Law—
What it changes · CRS summary

Written by the Congressional Research Service [2]. 112 words.

Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

Context
Committees
House Veterans' Affairs Committee
Senate Veterans' Affairs Committee
Policy area
Armed Forces and National Security: 268 of 6,567 bills became law, 113th–118th (4.1%)
Sponsor
1 of 47 bills enacted since 2013
Text versions
3, from introduced in house to referred in senate · 421 words
Subjects
AsiaCancerConflicts and warsCongressional oversightGovernment studies and investigationsHealth information and medical records +3 more
Latest action
Apr 8, 2025: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Records
Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 0

The bill status record lists no related bills.

Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]